San Francisco, CANCT07680842Now EnrollingIRB Ready

Drug-Resistant Epilepsy Clinical Trial in San Francisco, CA

Access cutting-edge drug-resistant epilepsy treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by University of California, San Francisco

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access drug-resistant epilepsy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related drug-resistant epilepsy treatment provided free

Apply for This San Francisco Location

Check if you qualify for this drug-resistant epilepsy clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Drug-Resistant Epilepsy Study in San Francisco

The goal of this study is to investigate the effects of a non-invasive, low intensity focused ultrasound (LIFU) stimulation on seizure frequency and the epileptogenic network in drug-resistant epilepsy. LIFU uses focused sound waves to modulate deep brain regions and to enable changes in brain network activity. Encephalography (EEG) and behavioral tasks will also be used to study how LIFU affects brain activity.

Sponsor: University of California, San Francisco

Who Can Participate

Inclusion Criteria

Male or female between 21 and 65 years of age at screening
Clinical diagnosis of drug-resistant epilepsy with on average, 4 or more seizures per month.
Able to provide informed consent (or assent when applicable) by the subject or subject's legal representative.
Be willing to undergo a brain MRI.
Be able and willing to wear a headband during the treatment duration.
Be able to complete scheduled visits and daily seizure logs.

Exclusion Criteria

Has a craniotomy or pathologic intracranial lesion (e.g. vascular malformations) in the trajectory of the focused ultrasound beam.
Pregnant, breastfeeding, is attempting pregnancy, or unwilling to practice birth control during participation in the study.
Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
Has any unstable medical or psychiatric disease.
Any contraindications for completing a brain MRI scan.
Has evidence of any other clinically relevant neurological disorder at the time of screening, including Alzheimer's disease, frontotemporal dementia, Huntington's disease, amyotrophic lateral sclerosis, and multiple sclerosis.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT07680842) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Drug-Resistant Epilepsy Treatment Options in San Francisco, CA

If you're searching for drug-resistant epilepsy treatment options in San Francisco, CA, this clinical trial (NCT07680842) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced drug-resistant epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all drug-resistant epilepsy clinical trials near you to find additional studies recruiting in your area.

More Epilepsy Trials in San Francisco, CA

See all epilepsy clinical trials recruiting in San Francisco — not just this study.

Browse Epilepsy Trials in San Francisco →

Browse More Trials by Condition

Epilepsy TrialsAll Conditions →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA